Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.29726259 |
2 | L-phenylalanine catabolic process (GO:0006559) | 5.29726259 |
3 | indole-containing compound catabolic process (GO:0042436) | 5.14236743 |
4 | indolalkylamine catabolic process (GO:0046218) | 5.14236743 |
5 | tryptophan catabolic process (GO:0006569) | 5.14236743 |
6 | aromatic amino acid family catabolic process (GO:0009074) | 5.14142026 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.00375593 |
8 | L-phenylalanine metabolic process (GO:0006558) | 5.00375593 |
9 | behavioral response to nicotine (GO:0035095) | 4.89132511 |
10 | tryptophan metabolic process (GO:0006568) | 4.77532479 |
11 | kynurenine metabolic process (GO:0070189) | 4.57508586 |
12 | protein carboxylation (GO:0018214) | 4.43353178 |
13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.43353178 |
14 | L-fucose catabolic process (GO:0042355) | 4.42589603 |
15 | fucose catabolic process (GO:0019317) | 4.42589603 |
16 | L-fucose metabolic process (GO:0042354) | 4.42589603 |
17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.38556111 |
18 | urea cycle (GO:0000050) | 4.32373619 |
19 | urea metabolic process (GO:0019627) | 4.32373619 |
20 | activated T cell proliferation (GO:0050798) | 4.09450848 |
21 | amine catabolic process (GO:0009310) | 4.08205392 |
22 | cellular biogenic amine catabolic process (GO:0042402) | 4.08205392 |
23 | regulation of fibrinolysis (GO:0051917) | 4.06868763 |
24 | bile acid biosynthetic process (GO:0006699) | 4.04735225 |
25 | negative regulation of fibrinolysis (GO:0051918) | 4.01748489 |
26 | nitrogen cycle metabolic process (GO:0071941) | 4.01448626 |
27 | high-density lipoprotein particle remodeling (GO:0034375) | 3.99572725 |
28 | regulation of protein activation cascade (GO:2000257) | 3.94505073 |
29 | DNA deamination (GO:0045006) | 3.93895078 |
30 | complement activation, alternative pathway (GO:0006957) | 3.90305713 |
31 | glyoxylate metabolic process (GO:0046487) | 3.82848626 |
32 | cellular glucuronidation (GO:0052695) | 3.79328345 |
33 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.71884296 |
34 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.71884296 |
35 | regulation of complement activation (GO:0030449) | 3.64170805 |
36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.58348524 |
37 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.57691582 |
38 | sulfur amino acid catabolic process (GO:0000098) | 3.56483307 |
39 | glucuronate metabolic process (GO:0019585) | 3.56320982 |
40 | uronic acid metabolic process (GO:0006063) | 3.56320982 |
41 | aromatic amino acid family metabolic process (GO:0009072) | 3.55933736 |
42 | indolalkylamine metabolic process (GO:0006586) | 3.54792919 |
43 | aldehyde catabolic process (GO:0046185) | 3.51798098 |
44 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.50622299 |
45 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.50622299 |
46 | cell wall macromolecule metabolic process (GO:0044036) | 3.49827341 |
47 | omega-hydroxylase P450 pathway (GO:0097267) | 3.49093049 |
48 | regulation of triglyceride catabolic process (GO:0010896) | 3.48705281 |
49 | regulation of cholesterol esterification (GO:0010872) | 3.48567359 |
50 | macromolecular complex remodeling (GO:0034367) | 3.46819313 |
51 | plasma lipoprotein particle remodeling (GO:0034369) | 3.46819313 |
52 | protein-lipid complex remodeling (GO:0034368) | 3.46819313 |
53 | fibrinolysis (GO:0042730) | 3.43799716 |
54 | reverse cholesterol transport (GO:0043691) | 3.43322511 |
55 | bile acid metabolic process (GO:0008206) | 3.42347489 |
56 | NAD biosynthetic process (GO:0009435) | 3.42108202 |
57 | phospholipid efflux (GO:0033700) | 3.41108729 |
58 | bile acid and bile salt transport (GO:0015721) | 3.38271582 |
59 | plasma lipoprotein particle clearance (GO:0034381) | 3.35030536 |
60 | imidazole-containing compound metabolic process (GO:0052803) | 3.32504089 |
61 | arginine metabolic process (GO:0006525) | 3.31329018 |
62 | disruption of cells of other organism (GO:0044364) | 3.29937643 |
63 | killing of cells of other organism (GO:0031640) | 3.29937643 |
64 | opsonization (GO:0008228) | 3.29833329 |
65 | serine family amino acid catabolic process (GO:0009071) | 3.28831122 |
66 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.28155744 |
67 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.28155744 |
68 | alpha-linolenic acid metabolic process (GO:0036109) | 3.27879733 |
69 | acylglycerol homeostasis (GO:0055090) | 3.24432117 |
70 | triglyceride homeostasis (GO:0070328) | 3.24432117 |
71 | low-density lipoprotein particle remodeling (GO:0034374) | 3.24219497 |
72 | homocysteine metabolic process (GO:0050667) | 3.24009932 |
73 | neural tube formation (GO:0001841) | 3.20893152 |
74 | blood coagulation, intrinsic pathway (GO:0007597) | 3.17788547 |
75 | cysteine metabolic process (GO:0006534) | 3.15821489 |
76 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.13754727 |
77 | plasma lipoprotein particle assembly (GO:0034377) | 3.12986158 |
78 | protein activation cascade (GO:0072376) | 3.12527653 |
79 | cholesterol efflux (GO:0033344) | 3.11277873 |
80 | positive regulation of defense response to virus by host (GO:0002230) | 3.11077136 |
81 | alpha-amino acid catabolic process (GO:1901606) | 3.09661894 |
82 | protein neddylation (GO:0045116) | 3.07201605 |
83 | amino-acid betaine metabolic process (GO:0006577) | 3.04809267 |
84 | acute-phase response (GO:0006953) | 3.04791649 |
85 | tyrosine metabolic process (GO:0006570) | 3.04487437 |
86 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.03149686 |
87 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.01270373 |
88 | benzene-containing compound metabolic process (GO:0042537) | 2.97547424 |
89 | complement activation, classical pathway (GO:0006958) | 2.97312896 |
90 | dopamine transport (GO:0015872) | 2.97231995 |
91 | negative regulation of lipase activity (GO:0060192) | 2.95013652 |
92 | neutrophil activation involved in immune response (GO:0002283) | 2.92615458 |
93 | glycine metabolic process (GO:0006544) | 2.92075030 |
94 | positive regulation of coagulation (GO:0050820) | 2.91532183 |
95 | complement activation (GO:0006956) | 2.90932162 |
96 | coenzyme catabolic process (GO:0009109) | 2.90670141 |
97 | plasma lipoprotein particle organization (GO:0071827) | 2.89061332 |
98 | ethanol oxidation (GO:0006069) | 2.88408440 |
99 | phospholipid homeostasis (GO:0055091) | 2.87918831 |
100 | positive regulation of hemostasis (GO:1900048) | 2.85685252 |
101 | positive regulation of blood coagulation (GO:0030194) | 2.85685252 |
102 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.85107252 |
103 | cofactor catabolic process (GO:0051187) | 2.84535669 |
104 | N-acetylneuraminate metabolic process (GO:0006054) | 2.82654739 |
105 | cellular response to exogenous dsRNA (GO:0071360) | 2.81729759 |
106 | regulation of action potential (GO:0098900) | 2.80321232 |
107 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.80162945 |
108 | detection of light stimulus involved in visual perception (GO:0050908) | 2.80162945 |
109 | serine family amino acid biosynthetic process (GO:0009070) | 2.80019129 |
110 | negative regulation of hemostasis (GO:1900047) | 2.79676746 |
111 | negative regulation of blood coagulation (GO:0030195) | 2.79676746 |
112 | cellular amino acid catabolic process (GO:0009063) | 2.77599328 |
113 | protein-lipid complex assembly (GO:0065005) | 2.77299507 |
114 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.76714010 |
115 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.76459811 |
116 | cell wall macromolecule catabolic process (GO:0016998) | 2.74943587 |
117 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.73861139 |
118 | negative regulation of cholesterol transport (GO:0032375) | 2.72709674 |
119 | negative regulation of sterol transport (GO:0032372) | 2.72709674 |
120 | negative regulation of mast cell activation (GO:0033004) | 2.72568152 |
121 | serine family amino acid metabolic process (GO:0009069) | 2.71558434 |
122 | protein-lipid complex subunit organization (GO:0071825) | 2.69883588 |
123 | regulation of mast cell activation (GO:0033003) | 2.69530777 |
124 | mast cell degranulation (GO:0043303) | 2.69079024 |
125 | mast cell activation involved in immune response (GO:0002279) | 2.69079024 |
126 | cholesterol homeostasis (GO:0042632) | 2.68852405 |
127 | tolerance induction (GO:0002507) | 2.67985183 |
128 | response to peptidoglycan (GO:0032494) | 2.67201893 |
129 | neutrophil activation (GO:0042119) | 2.64978804 |
130 | basic amino acid transport (GO:0015802) | 2.64733547 |
131 | multicellular organism reproduction (GO:0032504) | 2.64379038 |
132 | cellular ketone body metabolic process (GO:0046950) | 2.63773725 |
133 | mast cell activation (GO:0045576) | 2.63278831 |
134 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.62948753 |
135 | interferon-gamma production (GO:0032609) | 2.59611278 |
136 | opioid receptor signaling pathway (GO:0038003) | 2.59398294 |
137 | exogenous drug catabolic process (GO:0042738) | 2.58542785 |
138 | regulation of memory T cell differentiation (GO:0043380) | 2.57313035 |
139 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.57111006 |
140 | negative regulation of interleukin-1 production (GO:0032692) | 2.55658732 |
141 | N-acetylglucosamine metabolic process (GO:0006044) | 2.55446247 |
142 | negative regulation of cell killing (GO:0031342) | 2.52466603 |
143 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.52466603 |
144 | fucosylation (GO:0036065) | 2.51986128 |
145 | piRNA metabolic process (GO:0034587) | 2.51062780 |
146 | adaptation of signaling pathway (GO:0023058) | 2.48472400 |
147 | histamine transport (GO:0051608) | 2.47886049 |
148 | platelet dense granule organization (GO:0060155) | 2.47401800 |
149 | pantothenate metabolic process (GO:0015939) | 2.44999073 |
150 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.44404724 |
151 | macroautophagy (GO:0016236) | 2.43336946 |
152 | T cell proliferation (GO:0042098) | 2.42440410 |
153 | cornea development in camera-type eye (GO:0061303) | 2.41685733 |
154 | drug catabolic process (GO:0042737) | 2.41211031 |
155 | positive regulation of mast cell activation (GO:0033005) | 2.39959301 |
156 | negative regulation of protein autophosphorylation (GO:0031953) | 2.39667893 |
157 | S-adenosylmethionine metabolic process (GO:0046500) | 2.38996221 |
158 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.38661843 |
159 | hepatocyte apoptotic process (GO:0097284) | 2.38180136 |
160 | polyol catabolic process (GO:0046174) | 2.37812620 |
161 | DNA methylation involved in gamete generation (GO:0043046) | 2.37332089 |
162 | negative regulation of T cell mediated immunity (GO:0002710) | 2.37165827 |
163 | indole-containing compound metabolic process (GO:0042430) | 2.36319074 |
164 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.35764483 |
165 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.35764483 |
166 | NADH dehydrogenase complex assembly (GO:0010257) | 2.35764483 |
167 | neuronal action potential (GO:0019228) | 2.31207994 |
168 | sulfation (GO:0051923) | 2.28042753 |
169 | epithelial cilium movement (GO:0003351) | 2.27753936 |
170 | ketone body metabolic process (GO:1902224) | 2.26888730 |
171 | keratinocyte development (GO:0003334) | 2.26003099 |
172 | leukocyte degranulation (GO:0043299) | 2.25746994 |
173 | rRNA catabolic process (GO:0016075) | 2.24369428 |
174 | RNA destabilization (GO:0050779) | 2.24327938 |
175 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.24257408 |
176 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.23677166 |
177 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.23677166 |
178 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.23677166 |
179 | protein complex biogenesis (GO:0070271) | 2.23497346 |
180 | regulation of hippo signaling (GO:0035330) | 2.23303071 |
181 | snRNA transcription (GO:0009301) | 2.23176613 |
182 | lysosome localization (GO:0032418) | 2.22803265 |
183 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.22720365 |
184 | parturition (GO:0007567) | 2.22150098 |
185 | regulation of cilium movement (GO:0003352) | 2.21213242 |
186 | cytidine metabolic process (GO:0046087) | 2.20883709 |
187 | cytidine catabolic process (GO:0006216) | 2.20883709 |
188 | cytidine deamination (GO:0009972) | 2.20883709 |
189 | oxidative demethylation (GO:0070989) | 2.18108528 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.47522409 |
2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.00700014 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.34932749 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.61618794 |
5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.20585041 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.19894253 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.78522681 |
8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.62292800 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.26016304 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.24819233 |
11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.16477214 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.03095299 |
13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.72859867 |
14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.58477264 |
15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.58061688 |
16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.56512808 |
17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.55198739 |
18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.43480260 |
19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.40712635 |
20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.28328106 |
21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21000852 |
22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.20637156 |
23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.19582774 |
24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.13902976 |
25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.07906286 |
26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.07884582 |
27 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.07730613 |
28 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.99746836 |
29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.94307882 |
30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92947535 |
31 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.90417773 |
32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87342418 |
33 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.81756870 |
34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.79750713 |
35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73687302 |
36 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.69148095 |
37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.67720297 |
38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.66515794 |
39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65740096 |
40 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.63311554 |
41 | GATA3_26560356_Chip-Seq_TH2_Human | 1.52164128 |
42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50196735 |
43 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.49546167 |
44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46894701 |
45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45579337 |
46 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.43680088 |
47 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.41109555 |
48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40653467 |
49 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.39562391 |
50 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39494753 |
51 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.37879981 |
52 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.33848073 |
53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32470571 |
54 | ERA_21632823_ChIP-Seq_H3396_Human | 1.32302783 |
55 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.30072089 |
56 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.29043582 |
57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.28961138 |
58 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.25047434 |
59 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24493594 |
60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23205960 |
61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22514863 |
62 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.21156100 |
63 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.21156100 |
64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20664535 |
65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19138222 |
66 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17689879 |
67 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17689879 |
68 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.17526547 |
69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17336260 |
70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17210890 |
71 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.16431070 |
72 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16335959 |
73 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15930022 |
74 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15909185 |
75 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.15444593 |
76 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.15444593 |
77 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.14996719 |
78 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.14880663 |
79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14212908 |
80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13814887 |
81 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.13392969 |
82 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13251907 |
83 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.13096486 |
84 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12665121 |
85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.12665121 |
86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12472287 |
87 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.11820229 |
88 | NCOR_22424771_ChIP-Seq_293T_Human | 1.11791251 |
89 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.11456212 |
90 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.09636230 |
91 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09615889 |
92 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09213901 |
93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09068239 |
94 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08738734 |
95 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08229991 |
96 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07787322 |
97 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07396504 |
98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06759815 |
99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06301634 |
100 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06086784 |
101 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.05330214 |
102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05177740 |
103 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05177740 |
104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04910452 |
105 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04680134 |
106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04635483 |
107 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03872688 |
108 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.03268799 |
109 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.03057416 |
110 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03019156 |
111 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.02468439 |
112 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01946176 |
113 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.01879435 |
114 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01854642 |
115 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.01707616 |
116 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.01294140 |
117 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00621674 |
118 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00319579 |
119 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99047243 |
120 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98546166 |
121 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.98378865 |
122 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97364292 |
123 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.97077988 |
124 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.96989379 |
125 | MYB_26560356_Chip-Seq_TH2_Human | 0.96866810 |
126 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96865922 |
127 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.96466134 |
128 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.96161050 |
129 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94833274 |
130 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94720309 |
131 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94339263 |
132 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93188365 |
133 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.92836219 |
134 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.92530155 |
135 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.92456090 |
136 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92428285 |
137 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.92336357 |
138 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.92195296 |
139 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91222452 |
140 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91059841 |
141 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.90961639 |
142 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.90706048 |
143 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88844822 |
144 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87819334 |
145 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87132103 |
146 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.86772838 |
147 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86401441 |
148 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86302766 |
149 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.85876713 |
150 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.85782632 |
151 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83938276 |
152 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.83381580 |
153 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83176613 |
154 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82437548 |
155 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82160430 |
156 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.81745428 |
157 | AR_20517297_ChIP-Seq_VCAP_Human | 0.81566447 |
158 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80682704 |
159 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.79288034 |
160 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.79232170 |
161 | MYB_26560356_Chip-Seq_TH1_Human | 0.79175363 |
162 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78344424 |
163 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.77978454 |
164 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.77810279 |
165 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.76411655 |
166 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.76248970 |
167 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.76248970 |
168 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.76246834 |
169 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.74932805 |
170 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.74828806 |
171 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.73470081 |
172 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72626702 |
173 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.72509860 |
174 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.72430732 |
175 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.72310980 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.64807657 |
2 | MP0005360_urolithiasis | 4.87839801 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.35761572 |
4 | MP0005365_abnormal_bile_salt | 3.94948944 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.32038135 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.01010142 |
7 | MP0003252_abnormal_bile_duct | 2.70750590 |
8 | MP0003787_abnormal_imprinting | 2.45918772 |
9 | MP0005083_abnormal_biliary_tract | 2.38943160 |
10 | MP0009840_abnormal_foam_cell | 2.37878746 |
11 | MP0003724_increased_susceptibility_to | 2.12944383 |
12 | MP0009697_abnormal_copulation | 2.10296062 |
13 | MP0010329_abnormal_lipoprotein_level | 2.09819017 |
14 | MP0008877_abnormal_DNA_methylation | 2.07283989 |
15 | MP0001666_abnormal_nutrient_absorption | 1.93752914 |
16 | MP0003436_decreased_susceptibility_to | 1.92360682 |
17 | MP0002138_abnormal_hepatobiliary_system | 1.92022786 |
18 | MP0001919_abnormal_reproductive_system | 1.89782655 |
19 | MP0003191_abnormal_cellular_cholesterol | 1.84631588 |
20 | MP0005551_abnormal_eye_electrophysiolog | 1.83589837 |
21 | * MP0001835_abnormal_antigen_presentation | 1.83083069 |
22 | MP0002837_dystrophic_cardiac_calcinosis | 1.81414485 |
23 | MP0000569_abnormal_digit_pigmentation | 1.81219985 |
24 | MP0001986_abnormal_taste_sensitivity | 1.80574217 |
25 | MP0009764_decreased_sensitivity_to | 1.79740781 |
26 | MP0009785_altered_susceptibility_to | 1.79126181 |
27 | MP0001968_abnormal_touch/_nociception | 1.76105620 |
28 | MP0003195_calcinosis | 1.74400502 |
29 | MP0008872_abnormal_physiological_respon | 1.73005897 |
30 | MP0008004_abnormal_stomach_pH | 1.71288757 |
31 | MP0005332_abnormal_amino_acid | 1.62846969 |
32 | MP0000427_abnormal_hair_cycle | 1.61636927 |
33 | * MP0002419_abnormal_innate_immunity | 1.61466065 |
34 | MP0003011_delayed_dark_adaptation | 1.61091835 |
35 | MP0003186_abnormal_redox_activity | 1.60860693 |
36 | MP0005646_abnormal_pituitary_gland | 1.57816124 |
37 | MP0005084_abnormal_gallbladder_morpholo | 1.57696098 |
38 | MP0004381_abnormal_hair_follicle | 1.57050445 |
39 | MP0005167_abnormal_blood-brain_barrier | 1.53384816 |
40 | MP0000566_synostosis | 1.52851340 |
41 | MP0002693_abnormal_pancreas_physiology | 1.51787442 |
42 | MP0004043_abnormal_pH_regulation | 1.50567342 |
43 | MP0005408_hypopigmentation | 1.48264479 |
44 | MP0002102_abnormal_ear_morphology | 1.47653752 |
45 | MP0000609_abnormal_liver_physiology | 1.47385216 |
46 | MP0004142_abnormal_muscle_tone | 1.44220454 |
47 | MP0005464_abnormal_platelet_physiology | 1.43578105 |
48 | MP0003172_abnormal_lysosome_physiology | 1.42377968 |
49 | MP0001853_heart_inflammation | 1.40418315 |
50 | * MP0005025_abnormal_response_to | 1.39379390 |
51 | MP0002736_abnormal_nociception_after | 1.38603105 |
52 | MP0010368_abnormal_lymphatic_system | 1.38179017 |
53 | MP0001764_abnormal_homeostasis | 1.37165568 |
54 | MP0003868_abnormal_feces_composition | 1.35595175 |
55 | MP0004019_abnormal_vitamin_homeostasis | 1.32663818 |
56 | MP0005410_abnormal_fertilization | 1.32554539 |
57 | MP0009379_abnormal_foot_pigmentation | 1.31698825 |
58 | MP0006082_CNS_inflammation | 1.31207936 |
59 | MP0002148_abnormal_hypersensitivity_rea | 1.28730955 |
60 | MP0005451_abnormal_body_composition | 1.28256628 |
61 | MP0003646_muscle_fatigue | 1.28140861 |
62 | MP0008469_abnormal_protein_level | 1.27850659 |
63 | MP0003656_abnormal_erythrocyte_physiolo | 1.26339113 |
64 | MP0000230_abnormal_systemic_arterial | 1.25598943 |
65 | MP0005389_reproductive_system_phenotype | 1.25112693 |
66 | MP0002118_abnormal_lipid_homeostasis | 1.19767462 |
67 | MP0005319_abnormal_enzyme/_coenzyme | 1.19684123 |
68 | MP0001790_abnormal_immune_system | 1.19603788 |
69 | MP0005387_immune_system_phenotype | 1.19603788 |
70 | MP0006036_abnormal_mitochondrial_physio | 1.16012981 |
71 | MP0002132_abnormal_respiratory_system | 1.15606274 |
72 | MP0005645_abnormal_hypothalamus_physiol | 1.14985343 |
73 | MP0005253_abnormal_eye_physiology | 1.13901391 |
74 | MP0005075_abnormal_melanosome_morpholog | 1.12220413 |
75 | MP0001529_abnormal_vocalization | 1.09431639 |
76 | * MP0009763_increased_sensitivity_to | 1.08769484 |
77 | MP0005310_abnormal_salivary_gland | 1.08738099 |
78 | MP0006072_abnormal_retinal_apoptosis | 1.08087700 |
79 | * MP0001800_abnormal_humoral_immune | 1.07751781 |
80 | MP0006035_abnormal_mitochondrial_morpho | 1.05413271 |
81 | * MP0002452_abnormal_antigen_presenting | 1.05407165 |
82 | MP0005000_abnormal_immune_tolerance | 1.03701501 |
83 | MP0001845_abnormal_inflammatory_respons | 1.03096051 |
84 | MP0000470_abnormal_stomach_morphology | 1.03071463 |
85 | MP0000598_abnormal_liver_morphology | 1.01672841 |
86 | MP0001533_abnormal_skeleton_physiology | 1.00351561 |
87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97944653 |
88 | MP0000465_gastrointestinal_hemorrhage | 0.97312931 |
89 | MP0000685_abnormal_immune_system | 0.96824582 |
90 | MP0001905_abnormal_dopamine_level | 0.96642956 |
91 | MP0005409_darkened_coat_color | 0.95551541 |
92 | MP0004484_altered_response_of | 0.95337511 |
93 | * MP0002723_abnormal_immune_serum | 0.94285305 |
94 | MP0004782_abnormal_surfactant_physiolog | 0.94234719 |
95 | MP0003303_peritoneal_inflammation | 0.92199033 |
96 | MP0009046_muscle_twitch | 0.92091160 |
97 | MP0002928_abnormal_bile_duct | 0.91458587 |
98 | MP0002733_abnormal_thermal_nociception | 0.91350746 |
99 | MP0001970_abnormal_pain_threshold | 0.90673735 |
100 | MP0003763_abnormal_thymus_physiology | 0.89596976 |
101 | MP0001765_abnormal_ion_homeostasis | 0.89310401 |
102 | * MP0002398_abnormal_bone_marrow | 0.88665991 |
103 | MP0000015_abnormal_ear_pigmentation | 0.88347677 |
104 | MP0001756_abnormal_urination | 0.88109789 |
105 | MP0001873_stomach_inflammation | 0.86415541 |
106 | MP0002396_abnormal_hematopoietic_system | 0.86287104 |
107 | MP0005647_abnormal_sex_gland | 0.85320959 |
108 | MP0000343_altered_response_to | 0.85083750 |
109 | MP0004130_abnormal_muscle_cell | 0.85032490 |
110 | MP0002078_abnormal_glucose_homeostasis | 0.83459171 |
111 | MP0000858_altered_metastatic_potential | 0.83064225 |
112 | MP0010155_abnormal_intestine_physiology | 0.83012519 |
113 | MP0003638_abnormal_response/metabolism_ | 0.82955228 |
114 | MP0005448_abnormal_energy_balance | 0.82008341 |
115 | MP0001944_abnormal_pancreas_morphology | 0.81913285 |
116 | MP0005248_abnormal_Harderian_gland | 0.81033265 |
117 | * MP0001819_abnormal_immune_cell | 0.80517337 |
118 | MP0009745_abnormal_behavioral_response | 0.79717153 |
119 | MP0002277_abnormal_respiratory_mucosa | 0.79698284 |
120 | MP0005164_abnormal_response_to | 0.79522197 |
121 | MP0005671_abnormal_response_to | 0.79131515 |
122 | * MP0002420_abnormal_adaptive_immunity | 0.78808910 |
123 | MP0003045_fibrosis | 0.77893883 |
124 | * MP0002429_abnormal_blood_cell | 0.77663648 |
125 | MP0002160_abnormal_reproductive_system | 0.77510941 |
126 | MP0002722_abnormal_immune_system | 0.76099066 |
127 | MP0009643_abnormal_urine_homeostasis | 0.73206475 |
128 | MP0002166_altered_tumor_susceptibility | 0.73121435 |
129 | MP0005023_abnormal_wound_healing | 0.71728401 |
130 | MP0003136_yellow_coat_color | 0.71143444 |
131 | MP0002933_joint_inflammation | 0.69839542 |
132 | MP0004883_abnormal_blood_vessel | 0.69305622 |
133 | MP0002405_respiratory_system_inflammati | 0.68890441 |
134 | MP0002876_abnormal_thyroid_physiology | 0.67375385 |
135 | MP0000249_abnormal_blood_vessel | 0.66958272 |
136 | MP0005174_abnormal_tail_pigmentation | 0.66507213 |
137 | MP0003718_maternal_effect | 0.66221825 |
138 | MP0005670_abnormal_white_adipose | 0.66114881 |
139 | MP0003279_aneurysm | 0.65560380 |
140 | MP0009642_abnormal_blood_homeostasis | 0.64929574 |
141 | MP0005058_abnormal_lysosome_morphology | 0.64814524 |
142 | MP0003943_abnormal_hepatobiliary_system | 0.64463275 |
143 | MP0009053_abnormal_anal_canal | 0.64380636 |
144 | MP0005376_homeostasis/metabolism_phenot | 0.64204838 |
145 | MP0000767_abnormal_smooth_muscle | 0.63211571 |
146 | MP0003828_pulmonary_edema | 0.63191044 |
147 | * MP0000716_abnormal_immune_system | 0.60474828 |
148 | MP0009384_cardiac_valve_regurgitation | 0.60394855 |
149 | MP0006292_abnormal_olfactory_placode | 0.60306359 |
150 | MP0000689_abnormal_spleen_morphology | 0.60102369 |
151 | MP0000490_abnormal_crypts_of | 0.58824252 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Prolonged partial thromboplastin time (HP:0003645) | 5.67886462 |
2 | Deep venous thrombosis (HP:0002625) | 5.11656092 |
3 | Joint hemorrhage (HP:0005261) | 5.07657181 |
4 | Intrahepatic cholestasis (HP:0001406) | 4.97429817 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.97154808 |
6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.79501516 |
7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.30172983 |
8 | Xanthomatosis (HP:0000991) | 4.19567049 |
9 | Hypobetalipoproteinemia (HP:0003563) | 4.18937683 |
10 | Complement deficiency (HP:0004431) | 3.99417617 |
11 | Abnormality of the common coagulation pathway (HP:0010990) | 3.91112554 |
12 | Congenital stationary night blindness (HP:0007642) | 3.90365391 |
13 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.77345312 |
14 | Stomatitis (HP:0010280) | 3.66894016 |
15 | Hyperlipoproteinemia (HP:0010980) | 3.63109256 |
16 | Conjugated hyperbilirubinemia (HP:0002908) | 3.40121879 |
17 | Pancreatic cysts (HP:0001737) | 3.37616123 |
18 | Systemic lupus erythematosus (HP:0002725) | 3.36938858 |
19 | Reduced antithrombin III activity (HP:0001976) | 3.32632974 |
20 | Fat malabsorption (HP:0002630) | 3.30040533 |
21 | Abnormality of the intrinsic pathway (HP:0010989) | 3.25873424 |
22 | Abnormality of complement system (HP:0005339) | 3.24025046 |
23 | Epidermoid cyst (HP:0200040) | 3.22374452 |
24 | Eczematoid dermatitis (HP:0000976) | 3.20994971 |
25 | Abnormal drinking behavior (HP:0030082) | 3.20150168 |
26 | Polydipsia (HP:0001959) | 3.20150168 |
27 | Myocardial infarction (HP:0001658) | 3.20034840 |
28 | Hypolipoproteinemia (HP:0010981) | 3.13249860 |
29 | Abnormality of midbrain morphology (HP:0002418) | 3.11953377 |
30 | Molar tooth sign on MRI (HP:0002419) | 3.11953377 |
31 | Hyperglycinemia (HP:0002154) | 3.11483975 |
32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.10500372 |
33 | Nephronophthisis (HP:0000090) | 3.08616377 |
34 | Abnormality of methionine metabolism (HP:0010901) | 3.05156550 |
35 | Recurrent bacterial skin infections (HP:0005406) | 3.04901553 |
36 | Recurrent abscess formation (HP:0002722) | 3.02659086 |
37 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.02426927 |
38 | Pancreatic fibrosis (HP:0100732) | 2.97671114 |
39 | Chronic hepatic failure (HP:0100626) | 2.97133932 |
40 | Gingival bleeding (HP:0000225) | 2.95151286 |
41 | Abnormality of the renal cortex (HP:0011035) | 2.94283770 |
42 | Steatorrhea (HP:0002570) | 2.86499240 |
43 | Hyperammonemia (HP:0001987) | 2.82626678 |
44 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.79648493 |
45 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.78590818 |
46 | Abnormality of the renal medulla (HP:0100957) | 2.78470020 |
47 | Hypoalphalipoproteinemia (HP:0003233) | 2.72367537 |
48 | Glomerulonephritis (HP:0000099) | 2.64871452 |
49 | True hermaphroditism (HP:0010459) | 2.63351708 |
50 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.60276169 |
51 | Menorrhagia (HP:0000132) | 2.59739403 |
52 | Clumsiness (HP:0002312) | 2.59730887 |
53 | Hypoglycemic coma (HP:0001325) | 2.58297427 |
54 | Progressive cerebellar ataxia (HP:0002073) | 2.58219591 |
55 | Hypercholesterolemia (HP:0003124) | 2.56904738 |
56 | Attenuation of retinal blood vessels (HP:0007843) | 2.54214507 |
57 | Abolished electroretinogram (ERG) (HP:0000550) | 2.52431757 |
58 | Type II lissencephaly (HP:0007260) | 2.51003359 |
59 | Hypothermia (HP:0002045) | 2.50872602 |
60 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.47444874 |
61 | Tubular atrophy (HP:0000092) | 2.44258880 |
62 | Hyperventilation (HP:0002883) | 2.44248584 |
63 | Vacuolated lymphocytes (HP:0001922) | 2.44226870 |
64 | Inability to walk (HP:0002540) | 2.42066574 |
65 | Abnormality of nucleobase metabolism (HP:0010932) | 2.41972871 |
66 | Abnormality of glycine metabolism (HP:0010895) | 2.41714388 |
67 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.41714388 |
68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.40864632 |
69 | Ketoacidosis (HP:0001993) | 2.40108320 |
70 | Large for gestational age (HP:0001520) | 2.39600264 |
71 | Abnormality of serum amino acid levels (HP:0003112) | 2.38879386 |
72 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.34734819 |
73 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.34377983 |
74 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.33754463 |
75 | Polyuria (HP:0000103) | 2.33438483 |
76 | Hepatocellular carcinoma (HP:0001402) | 2.32930025 |
77 | Recurrent skin infections (HP:0001581) | 2.32158011 |
78 | Hyperbilirubinemia (HP:0002904) | 2.31814691 |
79 | Vascular calcification (HP:0004934) | 2.31742255 |
80 | Optic neuritis (HP:0100653) | 2.31208002 |
81 | Retrobulbar optic neuritis (HP:0100654) | 2.31208002 |
82 | Progressive inability to walk (HP:0002505) | 2.30990121 |
83 | Lipid accumulation in hepatocytes (HP:0006561) | 2.29565225 |
84 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.28525325 |
85 | Hyperglycinuria (HP:0003108) | 2.25962120 |
86 | Abnormality of iron homeostasis (HP:0011031) | 2.24916339 |
87 | Opisthotonus (HP:0002179) | 2.22074014 |
88 | Bile duct proliferation (HP:0001408) | 2.20874597 |
89 | Abnormal biliary tract physiology (HP:0012439) | 2.20874597 |
90 | Thrombophlebitis (HP:0004418) | 2.17652121 |
91 | Renal cortical cysts (HP:0000803) | 2.17535242 |
92 | Epistaxis (HP:0000421) | 2.16851346 |
93 | Abnormality of macrophages (HP:0004311) | 2.14955776 |
94 | Pulmonary embolism (HP:0002204) | 2.13725799 |
95 | Renal Fanconi syndrome (HP:0001994) | 2.13534393 |
96 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12941682 |
97 | Obstructive lung disease (HP:0006536) | 2.12941682 |
98 | Spontaneous abortion (HP:0005268) | 2.12873362 |
99 | Increased serum ferritin (HP:0003281) | 2.12232822 |
100 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.09360566 |
101 | Nephritis (HP:0000123) | 2.07446329 |
102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07330792 |
103 | Amyloidosis (HP:0011034) | 2.06439958 |
104 | Cardiovascular calcification (HP:0011915) | 2.04410570 |
105 | Abnormality of the prostate (HP:0008775) | 2.04211507 |
106 | Ketosis (HP:0001946) | 2.03993432 |
107 | Absent/shortened dynein arms (HP:0200106) | 2.02928955 |
108 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.02928955 |
109 | Lissencephaly (HP:0001339) | 2.02532937 |
110 | Cystic liver disease (HP:0006706) | 2.01653074 |
111 | Dry hair (HP:0011359) | 2.01610319 |
112 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.01476030 |
113 | Pancreatitis (HP:0001733) | 2.01185061 |
114 | Chromsome breakage (HP:0040012) | 2.00684169 |
115 | Disproportionate short-trunk short stature (HP:0003521) | 1.97803800 |
116 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96740358 |
117 | Dicarboxylic aciduria (HP:0003215) | 1.96740358 |
118 | Tetany (HP:0001281) | 1.95596863 |
119 | Gaze-evoked nystagmus (HP:0000640) | 1.95537785 |
120 | Exertional dyspnea (HP:0002875) | 1.95396056 |
121 | Elevated hepatic transaminases (HP:0002910) | 1.94950798 |
122 | Encephalitis (HP:0002383) | 1.94078969 |
123 | Decreased central vision (HP:0007663) | 1.93830913 |
124 | Hypochromic microcytic anemia (HP:0004840) | 1.93040827 |
125 | Mediastinal lymphadenopathy (HP:0100721) | 1.92734252 |
126 | Episodic fever (HP:0001954) | 1.92593764 |
127 | Purpura (HP:0000979) | 1.92278666 |
128 | Esophageal varix (HP:0002040) | 1.90291134 |
129 | Periodontitis (HP:0000704) | 1.89565518 |
130 | Abnormal urine output (HP:0012590) | 1.89565413 |
131 | Increased hepatocellular lipid droplets (HP:0006565) | 1.88792659 |
132 | Meningitis (HP:0001287) | 1.87756716 |
133 | Pendular nystagmus (HP:0012043) | 1.87624490 |
134 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.87011256 |
135 | Hypomagnesemia (HP:0002917) | 1.86610149 |
136 | Urticaria (HP:0001025) | 1.85971738 |
137 | Congenital hepatic fibrosis (HP:0002612) | 1.85829909 |
138 | Bulbous nose (HP:0000414) | 1.85424186 |
139 | Abnormal platelet volume (HP:0011876) | 1.85323970 |
140 | Prolonged bleeding time (HP:0003010) | 1.85242275 |
141 | Severe muscular hypotonia (HP:0006829) | 1.85173341 |
142 | Glycosuria (HP:0003076) | 1.85035192 |
143 | Abnormality of urine glucose concentration (HP:0011016) | 1.85035192 |
144 | Type I transferrin isoform profile (HP:0003642) | 1.84597543 |
145 | Recurrent fungal infections (HP:0002841) | 1.84019844 |
146 | Sclerocornea (HP:0000647) | 1.83489459 |
147 | Petechiae (HP:0000967) | 1.83123136 |
148 | Lower limb hyperreflexia (HP:0002395) | 1.82815738 |
149 | Nausea (HP:0002018) | 1.82616428 |
150 | Decreased circulating renin level (HP:0003351) | 1.82599510 |
151 | Constricted visual fields (HP:0001133) | 1.82457591 |
152 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.81632707 |
153 | Abnormality of alanine metabolism (HP:0010916) | 1.81302535 |
154 | Hyperalaninemia (HP:0003348) | 1.81302535 |
155 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.81302535 |
156 | Mitochondrial inheritance (HP:0001427) | 1.80965048 |
157 | Gastrointestinal infarctions (HP:0005244) | 1.80848498 |
158 | Hypochromic anemia (HP:0001931) | 1.80698311 |
159 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80128276 |
160 | Tinnitus (HP:0000360) | 1.79978754 |
161 | Abnormal ciliary motility (HP:0012262) | 1.79784984 |
162 | Orchitis (HP:0100796) | 1.79507585 |
163 | Gingivitis (HP:0000230) | 1.78418986 |
164 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.78192707 |
165 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.78192707 |
166 | Increased CSF lactate (HP:0002490) | 1.77748467 |
167 | Increased cerebral lipofuscin (HP:0011813) | 1.75099568 |
168 | Furrowed tongue (HP:0000221) | 1.74764159 |
169 | Abnormality of purine metabolism (HP:0004352) | 1.74286650 |
170 | Microcytic anemia (HP:0001935) | 1.74170919 |
171 | Generalized aminoaciduria (HP:0002909) | 1.73957615 |
172 | Anorexia (HP:0002039) | 1.73540783 |
173 | Hemorrhage of the eye (HP:0011885) | 1.73384633 |
174 | Genetic anticipation (HP:0003743) | 1.72592350 |
175 | Abnormality of T cell physiology (HP:0011840) | 1.72328942 |
176 | Myositis (HP:0100614) | 1.72052189 |
177 | Thyroid-stimulating hormone excess (HP:0002925) | 1.72036807 |
178 | Cerebral palsy (HP:0100021) | 1.71881331 |
179 | Metabolic acidosis (HP:0001942) | 1.71652751 |
180 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.71139585 |
181 | Lethargy (HP:0001254) | 1.71083131 |
182 | Acute hepatic failure (HP:0006554) | 1.70587737 |
183 | Recurrent cutaneous fungal infections (HP:0011370) | 1.69240854 |
184 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.69240854 |
185 | Absent speech (HP:0001344) | 1.68638710 |
186 | Abnormality of renal excretion (HP:0011036) | 1.67714856 |
187 | Abnormality of B cell number (HP:0010975) | 1.67232283 |
188 | Male pseudohermaphroditism (HP:0000037) | 1.65619182 |
189 | Protruding tongue (HP:0010808) | 1.65471345 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRAK4 | 3.84471448 |
2 | PINK1 | 3.20956544 |
3 | IRAK3 | 3.11862175 |
4 | ADRBK2 | 2.80982562 |
5 | BCKDK | 2.63327732 |
6 | TAOK3 | 2.41482566 |
7 | MAP3K14 | 2.29196231 |
8 | NME2 | 2.28636400 |
9 | NUAK1 | 2.24642869 |
10 | NEK9 | 2.18909951 |
11 | RIPK4 | 2.15292217 |
12 | WNK3 | 2.04256839 |
13 | IRAK1 | 1.97065091 |
14 | TRPM7 | 1.94069084 |
15 | ERN1 | 1.93309983 |
16 | EPHA3 | 1.83102908 |
17 | TLK1 | 1.75579932 |
18 | TYK2 | 1.73654501 |
19 | WNK4 | 1.66490776 |
20 | EPHB1 | 1.65344489 |
21 | GRK6 | 1.61300247 |
22 | ACVR1B | 1.61059116 |
23 | MAP4K2 | 1.59887133 |
24 | ZAK | 1.54360681 |
25 | TGFBR2 | 1.52335195 |
26 | FGFR4 | 1.52145765 |
27 | PBK | 1.50427238 |
28 | PIK3CG | 1.49946884 |
29 | TEC | 1.49862158 |
30 | MARK3 | 1.49278613 |
31 | PTK2B | 1.44657381 |
32 | DAPK2 | 1.44537516 |
33 | TXK | 1.42886444 |
34 | IRAK2 | 1.42256012 |
35 | LATS1 | 1.38842091 |
36 | TBK1 | 1.38413534 |
37 | INSRR | 1.37415637 |
38 | RPS6KA4 | 1.36554367 |
39 | PIM2 | 1.35643895 |
40 | MAP3K12 | 1.35471463 |
41 | FRK | 1.35398169 |
42 | SIK1 | 1.31624317 |
43 | BLK | 1.31296172 |
44 | ERBB4 | 1.30999676 |
45 | MAPK13 | 1.30178488 |
46 | MAP2K3 | 1.30114105 |
47 | OXSR1 | 1.29084404 |
48 | IKBKE | 1.25360511 |
49 | MAP2K7 | 1.20180019 |
50 | MAP4K1 | 1.20088831 |
51 | MAP2K4 | 1.18474535 |
52 | MAPK11 | 1.18137728 |
53 | EIF2AK2 | 1.15015447 |
54 | KDR | 1.13475252 |
55 | KIT | 1.12714317 |
56 | YES1 | 1.12372923 |
57 | NLK | 1.10591172 |
58 | CSK | 1.10321970 |
59 | ADRBK1 | 1.09833381 |
60 | CAMKK2 | 1.08641669 |
61 | GRK1 | 1.06039050 |
62 | STK38L | 1.05664207 |
63 | MAPK15 | 1.05191269 |
64 | SIK2 | 1.01675171 |
65 | IKBKB | 1.01363211 |
66 | PAK3 | 1.01003945 |
67 | * BTK | 0.99606350 |
68 | CLK1 | 0.98909388 |
69 | CSF1R | 0.98602716 |
70 | EIF2AK1 | 0.97783643 |
71 | MAPKAPK3 | 0.97647899 |
72 | EIF2AK3 | 0.96125248 |
73 | EPHA2 | 0.94672487 |
74 | MAP2K6 | 0.93045196 |
75 | JAK3 | 0.92799023 |
76 | STK10 | 0.91143392 |
77 | LYN | 0.87254164 |
78 | PIM1 | 0.85784652 |
79 | MST1R | 0.84591255 |
80 | CAMK1D | 0.84584323 |
81 | ABL2 | 0.84348417 |
82 | JAK1 | 0.82530190 |
83 | MAP3K3 | 0.81151258 |
84 | SGK2 | 0.79842002 |
85 | FES | 0.78485587 |
86 | BMPR1B | 0.77761467 |
87 | TIE1 | 0.74454869 |
88 | CHUK | 0.73972790 |
89 | STK39 | 0.73173350 |
90 | ZAP70 | 0.71723487 |
91 | STK11 | 0.71496665 |
92 | BMPR2 | 0.68805074 |
93 | FLT3 | 0.68717255 |
94 | PDK1 | 0.68594348 |
95 | MAP3K5 | 0.68477738 |
96 | PRKAA2 | 0.68310232 |
97 | DYRK2 | 0.67764533 |
98 | CSNK1G1 | 0.67568346 |
99 | MARK2 | 0.65985995 |
100 | PLK4 | 0.65884756 |
101 | STK3 | 0.65734881 |
102 | MUSK | 0.65730089 |
103 | CSNK1G2 | 0.65132940 |
104 | HCK | 0.64976741 |
105 | STK4 | 0.64513249 |
106 | CSNK1G3 | 0.64292864 |
107 | CDK3 | 0.63811349 |
108 | CDK6 | 0.63315221 |
109 | MATK | 0.63277058 |
110 | MAP3K1 | 0.63220763 |
111 | SYK | 0.61823363 |
112 | MAP3K7 | 0.61618651 |
113 | SIK3 | 0.61501495 |
114 | PRKG2 | 0.60504975 |
115 | PRKCI | 0.60311554 |
116 | PIK3CA | 0.60254683 |
117 | DYRK3 | 0.59400565 |
118 | CSNK1A1L | 0.59072579 |
119 | AKT3 | 0.58046159 |
120 | PHKG2 | 0.57141345 |
121 | PHKG1 | 0.57141345 |
122 | ERBB3 | 0.56337486 |
123 | ABL1 | 0.55149647 |
124 | OBSCN | 0.54194562 |
125 | MKNK1 | 0.53844902 |
126 | PRKCQ | 0.53771790 |
127 | PTK6 | 0.51731735 |
128 | MKNK2 | 0.51242459 |
129 | PKN1 | 0.51225068 |
130 | MAPK12 | 0.50959033 |
131 | PRKCZ | 0.50663457 |
132 | MAPK4 | 0.50608765 |
133 | MET | 0.49049406 |
134 | PRKCE | 0.48185525 |
135 | PRKD2 | 0.47867719 |
136 | SGK223 | 0.47756460 |
137 | SGK494 | 0.47756460 |
138 | GRK5 | 0.47411005 |
139 | STK16 | 0.47101883 |
140 | PDPK1 | 0.46710096 |
141 | MYLK | 0.46258996 |
142 | LCK | 0.45112682 |
143 | TNK2 | 0.44972740 |
144 | MAP3K11 | 0.42569150 |
145 | TNIK | 0.41269624 |
146 | CAMK1G | 0.40980616 |
147 | RPS6KA5 | 0.40739994 |
148 | GRK7 | 0.39923676 |
149 | CASK | 0.39626764 |
150 | RPS6KA6 | 0.39619317 |
151 | TTN | 0.39263806 |
152 | ITK | 0.37376190 |
153 | TAOK2 | 0.37162138 |
154 | PRKCD | 0.36575348 |
155 | CDK7 | 0.35944429 |
156 | GSK3A | 0.35811714 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.68741171 |
2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.54771673 |
3 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.08921781 |
4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.01391791 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.83859069 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.66079799 |
7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.48554020 |
8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.22751621 |
9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.17579302 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.15394417 |
11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.13855991 |
12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13267596 |
13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.12707151 |
14 | Peroxisome_Homo sapiens_hsa04146 | 2.06085382 |
15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.04240858 |
16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.02687023 |
17 | Retinol metabolism_Homo sapiens_hsa00830 | 1.99001418 |
18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.97890977 |
19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95817692 |
20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.80893599 |
21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75625789 |
22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.68692856 |
23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.66715045 |
24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.66564634 |
25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66173314 |
26 | Phototransduction_Homo sapiens_hsa04744 | 1.63119279 |
27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.57959011 |
28 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.57932620 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.56876196 |
30 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.55059344 |
31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.54555065 |
32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.54094965 |
33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52303106 |
34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.51504323 |
35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.51306727 |
36 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.50504109 |
37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.48336716 |
38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.47257335 |
39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.46914007 |
40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.44015464 |
41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.32959319 |
42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.31435732 |
43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28484874 |
44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.26105759 |
45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.22346550 |
46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21453156 |
47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.21076524 |
48 | ABC transporters_Homo sapiens_hsa02010 | 1.20450218 |
49 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.15858715 |
50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.13440799 |
51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12503129 |
52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.10787694 |
53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.08301700 |
54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07443701 |
55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06552935 |
56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03988532 |
57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03065415 |
58 | Platelet activation_Homo sapiens_hsa04611 | 0.98846408 |
59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96657933 |
60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95145621 |
61 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.93940889 |
62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92708350 |
63 | Protein export_Homo sapiens_hsa03060 | 0.92005842 |
64 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.91256648 |
65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90994033 |
66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89973692 |
67 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89659947 |
68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89111188 |
69 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88971889 |
70 | Leishmaniasis_Homo sapiens_hsa05140 | 0.88293230 |
71 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.87571081 |
72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87037565 |
73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86880381 |
74 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86284803 |
75 | RNA polymerase_Homo sapiens_hsa03020 | 0.85638003 |
76 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.85102581 |
77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.84959793 |
78 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82825237 |
79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80838569 |
80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.79180227 |
81 | Insulin secretion_Homo sapiens_hsa04911 | 0.77224065 |
82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.76152213 |
83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75910090 |
84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75141060 |
85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75056486 |
86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73120895 |
87 | Malaria_Homo sapiens_hsa05144 | 0.72837390 |
88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69752370 |
89 | Taste transduction_Homo sapiens_hsa04742 | 0.68039451 |
90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67738538 |
91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67597874 |
92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67346699 |
93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62353004 |
94 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61427583 |
95 | Lysine degradation_Homo sapiens_hsa00310 | 0.59510295 |
96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59111172 |
97 | Legionellosis_Homo sapiens_hsa05134 | 0.59029424 |
98 | Insulin resistance_Homo sapiens_hsa04931 | 0.58821999 |
99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58010642 |
100 | * Tuberculosis_Homo sapiens_hsa05152 | 0.56723837 |
101 | Morphine addiction_Homo sapiens_hsa05032 | 0.54510986 |
102 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.52793986 |
103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52357339 |
104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51911386 |
105 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.50785785 |
106 | * Pertussis_Homo sapiens_hsa05133 | 0.50781414 |
107 | Lysosome_Homo sapiens_hsa04142 | 0.50333287 |
108 | Measles_Homo sapiens_hsa05162 | 0.50193801 |
109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49888124 |
110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49044095 |
111 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.48997518 |
112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48807217 |
113 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.48242725 |
114 | Parkinsons disease_Homo sapiens_hsa05012 | 0.46763859 |
115 | Bile secretion_Homo sapiens_hsa04976 | 0.46437292 |
116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46200615 |
117 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.45940957 |
118 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.44205638 |
119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43876047 |
120 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43055490 |
121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41962198 |
122 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.41395413 |
123 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41062897 |
124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40493703 |
125 | Carbon metabolism_Homo sapiens_hsa01200 | 0.40256452 |
126 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40208783 |
127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40033963 |
128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39520593 |
129 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39450320 |
130 | RNA degradation_Homo sapiens_hsa03018 | 0.38210439 |
131 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.37526910 |
132 | Homologous recombination_Homo sapiens_hsa03440 | 0.34928843 |
133 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.32504452 |
134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.30373530 |
135 | DNA replication_Homo sapiens_hsa03030 | 0.29759623 |
136 | Influenza A_Homo sapiens_hsa05164 | 0.29505502 |
137 | Hepatitis C_Homo sapiens_hsa05160 | 0.27204538 |
138 | Allograft rejection_Homo sapiens_hsa05330 | 0.26950939 |
139 | Asthma_Homo sapiens_hsa05310 | 0.26298236 |
140 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.25270963 |
141 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.24237073 |
142 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.23734495 |
143 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.22423910 |
144 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21616248 |